Download PDF
Digestive Disease Interventions 2022; 06(04): 281-292
DOI: 10.1055/s-0042-1757762
Review Article

Partial Splenic Artery Embolization to Treat Portal Hypertension

Shanmukha Srinivas
1   Department of Radiology, University of California, San Diego, California
,
Akhilesh Yeluru
1   Department of Radiology, University of California, San Diego, California
,
Zachary T. Berman
1   Department of Radiology, University of California, San Diego, California
,
Jonas Redmond
1   Department of Radiology, University of California, San Diego, California
,
Jeet Minocha
1   Department of Radiology, University of California, San Diego, California
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Portal hypertension (PH) commonly occurs in the setting of underlying liver disease and can precipitate variceal bleeding and ascites among other complications. Traditionally, PH is managed with medication or lifestyle changes with refractory cases treated with transjugular intrahepatic portosystemic shunts or splenectomy. Partial splenic artery embolization (PSE) is an alternative treatment which may reduce PH by decreasing splenic vein inflow into the portal vein. In this article, we review the efficacy of PSE and present illustrative cases with a focus on technical and clinical considerations for embolization. We queried the PubMed database from August 1976 to September 2021 for clinical studies of PSE for the treatment of portal hypertension. For each article, the author, year, title, study design, number of patients, age, sex, liver function, technical considerations, adverse effects, and outcomes were recorded. We also review two successful and unsuccessful cases from our institution. A total of 12 studies were identified with 258 patients undergoing 290 PSE treatments. The mean age of patients was 44.1 years (range: 6–77). Most patients had well-compensated liver disease (Child–Pugh (CP) A; 35.1%) or significant functional compromise (CP-B; 44.4%), but a few had decompensated disease (CP-C; 8.9%). The majority (91.7%) of procedures were performed distally within the splenic artery, and on average, 59.5% (20–100) of the spleen underwent infarction. Common complications included symptoms of postembolization syndrome such as abdominal pain (58.5%) and fever (53.2%) as well as atelectasis (9.0%). Five PSE procedures (1.7%) resulted in death secondary to pleuropneumonia, splenic abscess, sepsis, intracranial hemorrhage, and pulmonary embolism, respectively. PSE is an effective but often underutilized treatment for PH. These benefits have risk for minor complications including postembolization syndrome and major complications such as splenic abscess formation. This article will introduce the reader to important technical and clinical considerations regarding PSE.

Keywords

partial splenic artery embolization - portal hypertension - variceal bleeding - ascites


Publication History

Received: 30 April 2022

Accepted: 22 August 2022

Article published online:
01 November 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Al-Busafi SA, McNabb-Baltar J, Farag A, Hilzenrat N. Clinical manifestations of portal hypertension. Int J Hepatol 2012; 2012: 203794
    PubMedGoogle Scholar
  • 2 Romano M, Giojelli A, Capuano G, Pomponi D, Salvatore M. Partial splenic embolization in patients with idiopathic portal hypertension. Eur J Radiol 2004; 49 (03) 268-273
    CrossrefPubMedGoogle Scholar
  • 3 Bari K, Garcia-Tsao G. Treatment of portal hypertension. World J Gastroenterol 2012; 18 (11) 1166-1175
    CrossrefPubMedGoogle Scholar
  • 4 Pålsson B, Hallén M, Forsberg AM, Alwmark A. Partial splenic embolization: long-term outcome. Langenbecks Arch Surg 2003; 387 (11-12): 421-426
    CrossrefPubMedGoogle Scholar
  • 5 Israel DM, Hassall E, Culham JA, Phillips RR. Partial splenic embolization in children with hypersplenism. J Pediatr 1994; 124 (01) 95-100
    CrossrefPubMedGoogle Scholar
  • 6 Han MJ, Zhao HG, Ren K, Zhao DC, Xu K, Zhang XT. Partial splenic embolization for hypersplenism concomitant with or after arterial embolization of hepatocellular carcinoma in 30 patients. Cardiovasc Intervent Radiol 1997; 20 (02) 125-127
    CrossrefPubMedGoogle Scholar
  • 7 Petersons A, Volrats O, Bernsteins A. The first experience with non-operative treatment of hypersplenism in children with portal hypertension. Eur J Pediatr Surg 2002; 12 (05) 299-303
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Xu RY, Liu B, Lin N. Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension. World J Gastroenterol 2004; 10 (07) 1072-1074
    CrossrefPubMedGoogle Scholar
  • 9 Chikamori F, Inoue A, Okamoto H, Kuniyoshi N, Kawashima T, Takase Y. Hemodynamic effects of combined therapy using partial splenic embolization and transjugular retrograde obliteration for gastric varices with gastrorenal shunt. World J Surg 2010; 34 (05) 1046-1051
    CrossrefPubMedGoogle Scholar
  • 10 Waguri N, Hayashi M, Yokoo T. et al. Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for portosystemic shunts. J Vasc Interv Radiol 2012; 23 (05) 650-657
    CrossrefPubMedGoogle Scholar
  • 11 Ozturk O, Eldem G, Peynircioglu B. et al. Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension. World J Gastroenterol 2016; 22 (43) 9623-9630
    CrossrefPubMedGoogle Scholar
  • 12 Pang X, Li T, Wang C. Splenic artery embolization with detachable balloons for hypersplenism. J Int Med Res 2018; 46 (10) 4111-4119
    CrossrefPubMedGoogle Scholar
  • 13 Kis B, Mills M, Smith J. et al. Partial splenic artery embolization in 35 cancer patients: results of a single institution retrospective study. J Vasc Interv Radiol 2020; 31 (04) 584-591
    CrossrefPubMedGoogle Scholar
  • 14 Ooka Y, Chiba T, Ogasawara S. et al. Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia. BioMed Res Int 2014; 2014: 960628
    CrossrefPubMedGoogle Scholar
  • 15 Sunakawa H, Tokuhara D, Yamamoto A. et al. Successful emergency combined therapy with partial splenic arterial embolization and endoscopic injection therapy against a bleeding duodenal varix in a child. Clin J Gastroenterol 2015; 8 (03) 138-142
    CrossrefPubMedGoogle Scholar
  • 16 Kimura F, Itoh H, Ambiru S. et al. Long-term results of initial and repeated partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura. AJR Am J Roentgenol 2002; 179 (05) 1323-1326
    CrossrefPubMedGoogle Scholar
  • 17 Smith MB. Handbook of interventional radiologic procedures, 4th ed. AJR Am J Roentgenol 2011; 197 (06) W1158
    CrossrefPubMedGoogle Scholar
  • 18 Ahuja C, Farsad K, Chadha M. An overview of splenic embolization. AJR Am J Roentgenol 2015; 205 (04) 720-725
    CrossrefPubMedGoogle Scholar
  • 19 Spigos DG, Jonasson O, Mozes M, Capek V. Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol 1979; 132 (05) 777-782
    CrossrefPubMedGoogle Scholar
  • 20 Bundy JJ, Hage AN, Srinivasa RN. et al. Intra-arterial ampicillin and gentamicin and the incidence of splenic abscesses following splenic artery embolization: a 20-year case control study. Clin Imaging 2019; 54: 6-11
    CrossrefPubMedGoogle Scholar
  • 21 Guan YS, Hu Y. Clinical application of partial splenic embolization. ScientificWorldJournal 2014; 2014: 961345
    PubMedGoogle Scholar
  • 22 Yoshida H, Mamada Y, Taniai N, Tajiri T. Partial splenic embolization. Hepatol Res 2008; 38 (03) 225-233
    CrossrefPubMedGoogle Scholar
  • 23 Liu J, Meng J, Yang M. et al. Two-step complete splenic artery embolization for the management of symptomatic sinistral portal hypertension. Scand J Gastroenterol 2022; 57 (01) 78-84
    CrossrefPubMedGoogle Scholar
  • 24 Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: a review of the English language literature. J Vasc Interv Radiol 2007; 18 (04) 463-481
    CrossrefPubMedGoogle Scholar
  • 25 Ishikawa T, Imai M, Okoshi M. et al. Cone beam versus conventional computed tomography angiography volume measurement in partial splenic embolization. Medicine (Baltimore) 2019; 98 (05) e14312
    CrossrefPubMedGoogle Scholar
  • 26 Zannini G, Masciariello S, Pagano G, Sangiuolo P, Zotti G, Iaccarino V. Percutaneous splenic artery occlusion for portal hypertension. A new mechanical technique for hypersplenism. Arch Surg 1983; 118 (08) 897-900
    CrossrefPubMedGoogle Scholar
  • 27 Nishida O, Moriyasu F, Nakamura T. et al. Interrelationship between splenic and superior mesenteric venous circulation manifested by transient splenic arterial occlusion using a balloon catheter. Hepatology 1987; 7 (03) 442-446
    CrossrefPubMedGoogle Scholar
  • 28 Ohmagari K, Toyonaga A, Tanikawa K. Effects of transcatheter splenic arterial embolization on portal hypertensive gastric mucosa. Am J Gastroenterol 1993; 88 (11) 1837-1841
    PubMedGoogle Scholar
  • 29 Nio M, Hayashi Y, Sano N, Ishii T, Sasaki H, Ohi R. Long-term efficacy of partial splenic embolization in children. J Pediatr Surg 2003; 38 (12) 1760-1762
    CrossrefPubMedGoogle Scholar
  • 30 Talwar A, Gabr A, Riaz A. et al. Adverse events related to partial splenic embolization for the treatment of hypersplenism: a systematic review. J Vasc Interv Radiol 2020; 31 (07) 1118-1131.e6
    CrossrefPubMedGoogle Scholar
  • 31 Ogawa S, Yamamoto A, Jogo A. et al. Splenic vein diameter is a risk factor for the portal venous system thrombosis after partial splenic artery embolization. Cardiovasc Intervent Radiol 2021; 44 (06) 921-930
    CrossrefPubMedGoogle Scholar
  • 32 Ishikawa T, Sasaki R, Nishimura T. et al. A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification. PLoS One 2019; 14 (09) e0223153
    CrossrefPubMedGoogle Scholar
  • 33 Ohmoto K, Yamamoto R, Yamamoto S. et al. [Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)]. Gan No Rinsho 1989; 35 (06) 690-695
    PubMedGoogle Scholar
  • 34 Boyer TD, Habib S. Big spleens and hypersplenism: fix it or forget it?. Liver Int 2015; 35 (05) 1492-1498
    CrossrefPubMedGoogle Scholar
  • 35 Yoshidome H, Kimura F, Shimizu H. et al. Usefulness of preoperative partial splenic embolization in hepatocellular carcinoma and hypersplenic thrombocytopenia. Hepatogastroenterology 2011; 58 (112) 2062-2066
    PubMedGoogle Scholar
  • 36 Kaihara T, Tanabe Y, Higuma T. et al. First case report of successful PCI with thrombocytopenia treated with partial splenic artery embolization. Cardiovasc Revasc Med 2019; 20 (11S): 34-36
    CrossrefPubMedGoogle Scholar
  • 37 Kim H, Suh KS, Jeon YM. et al. Partial splenic artery embolization for thrombocytopenia and uncontrolled massive ascites after liver transplantation. Transplant Proc 2012; 44 (03) 755-756
    CrossrefPubMedGoogle Scholar
  • 38 Madoff DC, Denys A, Wallace MJ. et al. Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics 2005; 25 (Suppl. 01) S191-S211
    CrossrefPubMedGoogle Scholar
  • 39 Smith M, Ray CE. Splenic artery embolization as an adjunctive procedure for portal hypertension. Semin Intervent Radiol 2012; 29 (02) 135-139
    Article in Thieme ConnectPubMedGoogle Scholar
  • 40 Masada T, Tanaka T, Sakaguchi H. et al. Coils versus gelatin particles with or without intraarterial antibiotics for partial splenic embolization: a comparative evaluation. J Vasc Interv Radiol 2014; 25 (06) 852-858
    CrossrefPubMedGoogle Scholar
  • 41 Zaitoun MMA, Basha MAA, Elsayed SB. et al. Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes. Insights Imaging 2021; 12 (01) 85
    CrossrefPubMedGoogle Scholar
  • 42 Olthof DC, van der Vlies CH, Joosse P, van Delden OM, Jurkovich GJ, Goslings JC. PYTHIA Collaboration Group. Consensus strategies for the nonoperative management of patients with blunt splenic injury: a Delphi study. J Trauma Acute Care Surg 2013; 74 (06) 1567-1574 [ Erratum in: J Trauma Acute Care Surg. 2013;75(2):353-4. van der Vlies, Cornelius H]
    CrossrefPubMedGoogle Scholar
  • 43 Hamidian Jahromi A, Migliaro M, Romano M, Sangster G. Delayed splenic rupture; normal appearing spleen on the initial multidetector computed tomography (MDCT) can sometimes be misleading. Trauma Mon 2016; 21 (05) e24465
    CrossrefPubMedGoogle Scholar
  • 44 Reynolds M, Donaldson JS, Vogelzang RL. Giant iatrogenic splenic pseudocyst. J Pediatr Surg 1989; 24 (07) 700-701 , discussion 701–702
    CrossrefPubMedGoogle Scholar
  • 45 Lo TJ, Lin KC. Acute pseudo-obstruction of the colon following partial splenic artery embolization: report of a case. J Formos Med Assoc 1992; 91 (03) 351-355
    PubMedGoogle Scholar
  • 46 Tekola BD, Arner DM, Behm BW. Coil migration after transarterial coil embolization of a splenic artery pseudoaneurysm. Case Rep Gastroenterol 2013; 7 (03) 487-491
    CrossrefPubMedGoogle Scholar
  • 47 Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology 1995; 22 (06) 1682-1688
    CrossrefPubMedGoogle Scholar
  • 48 Passhak M, Shachar SS, Ofer A, Beny A. Partial splenic embolization in the treatment of prolonged thrombocytopenia due to hypersplenism in metastatic cancer patients. Support Care Cancer 2018; 26 (10) 3527-3532
    CrossrefPubMedGoogle Scholar
  • 49 Lee CM, Leung TK, Wang HJ. et al. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol 2007; 13 (04) 619-622
    CrossrefPubMedGoogle Scholar
  • 50 Nagata J, Hirose S, Shiraishi K. et al. Vaginal bleeding in a patient with type C liver cirrhosis without a past history of laparotomy: successful treatment with partial splenic artery embolization. Clin J Gastroenterol 2012; 5 (04) 275-281
    CrossrefPubMedGoogle Scholar
  • 51 Nomiyama K, Akagi K, Watanabe H, Kajiwara E, Sakino I. [The effect of partial splenic embolization (PSE) on liver function test in patients with liver cirrhosis]. Fukuoka Igaku Zasshi 1991; 82 (03) 105-109
    PubMedGoogle Scholar
  • 52 Nishikubo H, Onda M, Tajiri T, Kim DY. [The evaluation of therapeutic effect on partial splenic embolization (PSE) for liver cirrhosis patients]. Nihon Shokakibyo Gakkai Zasshi 1996; 93 (01) 19-25
    PubMedGoogle Scholar
  • 53 Ishikawa T, Sasaki R, Nishimura T. et al. Short-term effects of hepatic arterial buffer responses induced by partial splenic embolization on the hepatic function of patients with cirrhosis according to the Child-Pugh classification. Intern Med 2021; 60 (09) 1331-1342
    CrossrefPubMedGoogle Scholar
  • 54 Hirooka M, Koizumi Y, Tanaka T. et al. Treatment on the spleen prevents the progression of secondary sarcopenia in patients with liver cirrhosis. Hepatol Commun 2020; 4 (12) 1812-1823
    CrossrefPubMedGoogle Scholar
  • 55 Philips CA, Kumar L, Augustine P. Partial splenic artery embolization for severe hepatic myelopathy in cirrhosis. Hepatology 2018; 67 (03) 1169-1171
    CrossrefPubMedGoogle Scholar
  • 56 Kuo F, Park J, Chen A. Coil-assisted retrograde transvenous obliteration and partial splenic artery embolization for hepatic encephalopathy. Hepatology 2017; 66 (04) 1347-1350
    CrossrefPubMedGoogle Scholar
  • 57 Iwamoto T, Saeki I, Hidaka I, Ishikawa T, Takami T, Sakaida I. Novel therapeutic strategy using interventional radiology (IVR) for hepatitis C virus (HCV)-related decompensated liver cirrhosis: a case report. Am J Case Rep 2019; 20: 1699-1704
    CrossrefPubMedGoogle Scholar
  • 58 Ishikawa T, Hamamoto K, Sasaki R. et al. Significant improvement in portal-systemic liver failure symptoms and successful management of portal-splenic venous hemodynamics by the combination of interventional radiology and pharmacotherapy. Hepatol Res 2020; 50 (10) 1201-1208
    CrossrefPubMedGoogle Scholar
  • 59 Yoshida H, Mamada Y, Taniai N. et al. Long-term results of partial splenic artery embolization as supplemental treatment for portal-systemic encephalopathy. Am J Gastroenterol 2005; 100 (01) 43-47
    CrossrefPubMedGoogle Scholar
  • 60 Bárcena R, Moreno A, Foruny JR. et al. Improved graft function in liver-transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome?. Clin Transplant 2006; 20 (04) 517-523
    CrossrefPubMedGoogle Scholar
  • 61 DuBois B, Mobley D, Chick JFB, Srinivasa RN, Wilcox C, Weintraub J. Efficacy and safety of partial splenic embolization for hypersplenism in pre- and post-liver transplant patients: a 16-year comparative analysis. Clin Imaging 2019; 54: 71-77
    CrossrefPubMedGoogle Scholar
  • 62 Wu T, Sun R, Huang Y. et al. Partial splenic embolization of patients with hypersplenism by transradial or transfemoral approach: a prospective randomized controlled trial. Acta Radiol 2016; 57 (10) 1201-1204
    CrossrefPubMedGoogle Scholar
  • 63 Chen Q, Li Z, Yang Y. et al. Partial splenic embolization through endoscopic ultrasound-guided implantation of coil as a potential technique to treat portal hypertension. Endoscopy 2021; 53 (02) E40-E41
    Article in Thieme ConnectPubMedGoogle Scholar
  • 64 Saddekni S, Moustafa AS, Tahoon HA, Setita M, Abdel-Aal AK. Treatment of hypersplenism by partial splenic embolization through gastric collaterals. J Radiol Case Rep 2016; 10 (03) 28-35
    PubMedGoogle Scholar
  • 65 Matsuoka S, Ishii T, Miyazawa S. et al. Utility of partial splenic embolization for hypersplenism using Guglielmi detachable coils. Hepatogastroenterology 2015; 62 (139) 683-687
    PubMedGoogle Scholar
  • 66 Link DP, Seibert JA, Gould J, Lantz BM. On-line monitoring of sequential blood flow reduction during splenic embolization. Acta Radiol 1989; 30 (01) 101-103
    CrossrefPubMedGoogle Scholar
  • 67 Link DP, Lantz BM, Seibert JA, Meyers FJ. Partial splenic embolization guided by blood flow measurements. Invest Radiol 1989; 24 (09) 678-683
    CrossrefPubMedGoogle Scholar
  • 68 Mukaiya M, Hirata K, Yamashiro K, Katsuramaki T, Kimura H, Denno R. Changes in portal hemodynamics and hepatic function after partial splenic embolization (PSE) and percutaneous transhepatic obliteration (PTO). Cancer Chemother Pharmacol 1994; 33 (Suppl): S37-S41
    CrossrefPubMedGoogle Scholar
  • 69 Helaly AZ, Al-Warraky MS, El-Azab GI, Kohla MA, Abdelaal EE. Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism. APMIS 2015; 123 (12) 1032-1039
    CrossrefPubMedGoogle Scholar
  • 70 Meine TC, Maschke SK, Kirstein MM. et al. Evaluation of perfusion changes using a 2D parametric parenchymal blood flow technique with automated vessel suppression following partial spleen embolization in patients with hypersplenism and portal hypertension. Medicine (Baltimore) 2021; 100 (07) e24783
    CrossrefPubMedGoogle Scholar
  • 71 Assal F, El Kassas M, Esmail E. et al. Microwave ablation in the spleen versus partial splenic artery embolisation: a new technique for hypersplenism in cirrhosis. Arab J Gastroenterol 2017; 18 (01) 25-29
    CrossrefPubMedGoogle Scholar